EDIT
Editas Medicine Inc
2.60$
+4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +271.6% | +126.8% | +132.6% | -35.7% | +341.9% | -71.8% | -22.8% | +296.3% | -58.6% | +25.4% | |
| – | +219.1% | +271.5% | +202.3% | +45.9% | +9.0% | +6.9% | +63.1% | -96.8% | +25.4% | -4.3% | +3,185.7% | -97.4% | |
| – | – | – | – | – | – | – | – | -71.8% | -22.8% | +265.6% | -331.7% | – | |
| – | +219.1% | +271.5% | +202.3% | +45.9% | +9.0% | +6.9% | +63.1% | -9.8% | +22.8% | +1.5% | +12.2% | -54.9% | |
| – | +110.7% | +136.5% | +155.7% | +9.2% | +8.9% | +17.4% | +4.7% | +12.7% | -7.2% | -1.5% | +3.4% | -30.7% | |
| – | +245.4% | +190.3% | +179.5% | +29.5% | +9.0% | -55.7% | +249.4% | -3.1% | +12.3% | -1.8% | -65.1% | +66.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +320.6% | -56.6% | +1,477.4% | +252.2% | +112.3% | -64.4% | +118.7% | -25.8% | – | – | +181.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,292.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.